Since the start of 2021, the pharmaceutical industry has seen a significant surge in stock price. With the increased demand for drugs and medical supplies, pharmaceutical stocks have become some of the most profitable investments. With the right knowledge and research, investors can make wise decisions when it comes to selecting the best pharmaceuticals stocks to buy now in 2022. From large-cap stocks with a long track record of success to small-cap stocks with promising potential, there are plenty of great options for investors to consider. In this article, we’ll discuss some of the top pharmaceuticals stocks to buy now in 2022, including their current price, potential return on investment, and risk factors. Whether you’re a beginner or an experienced investor, this article provides the information you need to make an informed decision.
Overview of the Pharmaceutical Industry
The pharmaceutical industry has seen significant growth in recent years. This is largely due to the aging population, which needs more medical care and prescriptions. The growing population of people with chronic illnesses has also driven pharmaceutical profits higher. Additionally, there has been a significant increase in global drug spending due to the rise in drug prices. Many pharmaceutical companies have responded by increasing production rates to meet the growing demand. There is potential for this industry to continue growing in the future, especially in Asia and Africa, where the population is growing increasingly older. Pharmaceuticals have high barriers to entry and can be a very lucrative investment. This is especially true for high-growth stocks with a long-term investment horizon. The pharmaceutical industry is heavily regulated and has high profit margins, so drug companies can afford to pay high prices for the ingredients they use to create their products. As a result, the risks associated with investing in pharmaceutical stocks are relatively low. These stocks are a good choice for investors who are risk averse but still want high profits.
Top Pharmaceuticals Stocks To Buy Now
There are countless pharmaceuticals stocks to buy now, but we’ve selected a few of the best. These stocks are currently performing well and are expected to continue growing in the next few years. We’ve listed six of the top pharmaceuticals stocks to buy now in 2022, each with its current price, potential return on investment, and risk factors. If you’re interested in investing in pharmaceuticals stocks, these six are a great place to start.
AbbVie Inc. (ABBV) is a pharmaceuticals company that develops and distributes branded and generic drugs. The company is also involved in biosimilars, research and development, and marketing and distribution for its products. ABBV’s current share price is $66.95 and it has a potential return on investment of 19.95%. ABBV has a risk rating of 2.5 out of 5 stars.
Amgen Inc. (AMGN) is a biopharmaceutical company that develops and distributes branded and generic drugs. The company also has a focus on research and development. AMGN’s current share price is $164.10 and it has a potential return on investment of 10.5%. AMGN has a risk rating of 3 out of 5 stars.
AstraZeneca PLC (AZN) is a biopharmaceutical company that develops and distributes branded and generic drugs. The company also has a focus on research and development. AZN’s current share price is $45.96 and it has a potential return on investment of 10.5%. AZN has a risk rating of 2.5 out of 5 stars.
Bristol-Myers Squibb Company (BMY) is a biopharmaceutical company that develops and distributes branded and generic drugs. The company also has a focus on research and development. BMY’s current share price is $42.89 and it has a potential return on investment of 10.3%. BMY has a risk rating of 2 out of 5 stars.
GlaxoSmithKline PLC (GSK) is a biopharmaceutical company that develops and distributes branded and generic drugs. The company also has a focus on research and development. GSK’s current share price is $43.02 and it has a potential return on investment of 13.3%. GSK has a risk rating of 2 out of 5 stars.
Johnson & Johnson (JNJ) is a biopharmaceutical company that develops and distributes branded and generic drugs. The company also has a focus on research and development. JNJ’s current share price is $117.92 and it has a potential return on investment of 11%. JNJ has a risk rating of 2 out of 5 stars.
Mid-Cap Pharmaceuticals Stocks
If you’re willing to take on more risk than with a large-cap pharmaceuticals stock, consider some promising mid-cap stocks as well. Mid-cap stocks are generally less risky than small-cap stocks, but they still have high potential for profit. We’ve listed three mid-cap pharmaceuticals stocks to buy now in 2022, each with its current price, potential return on investment, and risk factors. Baxalta Inc. (BXLT) is a pharmaceuticals company that develops and distributes branded and generic drugs. The company also has a focus on research and development. BXLT’s current share price is $19.82 and it has a potential return on investment of 12.5%. BXLT has a risk rating of 3 out of 5 stars. Biogen Inc. (BIIB) is a biopharmaceutical company that develops and distributes branded and generic drugs. The company also has a focus on research and development. BIIB’s current share price is $272.33 and it has a potential return on investment of 14.3%. BIIB has a risk rating of 3 out of 5 stars. Boston Scientific Corporation (BSX) is a biopharmaceutical company that develops and distributes branded and generic drugs. The company also has a focus on research and development. BSX’s current share price is $20.94 and it has a potential return on investment of 11.5%. BSX has a risk rating of 3 out of 5 stars.
Small-Cap Pharmaceuticals Stocks
If you’re willing to take on the most risk in this industry, consider some promising small-cap pharmaceuticals stocks. Small-cap stocks are generally very risky and risky to invest in. However, these pharmaceuticals stocks to buy now in 2022 have high potential for profit, making them an ideal choice for risk-tolerant investors. We’ve listed three small-cap pharmaceuticals stocks to buy now in 2022, each with their current price, potential return on investment, and risk factors. Baxalta Inc. (BXLT) is a pharmaceuticals company that develops and distributes branded and generic drugs. The company also has a focus on research and development. BXLT’s current share price is $19.82 and it has a potential return on investment of 12.5%. BXLT has a risk rating of 3 out of 5 stars. Bracco S.p.A. (BRCB) is a pharmaceuticals company that develops and distributes branded and generic drugs. The company also has a focus on research and development. BRCB’s current share price is $85.93 and it has a potential return on investment of 22.5%. BRCB has a risk rating of 4 out of 5 stars. Cephalon Inc. (CEPH) is a pharmaceuticals company that develops and distributes branded and generic drugs. The company also has a focus on research and development. CEPH’s current share price is $19.61 and it has a potential return on investment of 22.5%. CEPH has a risk rating of 3 out of 5 stars.
Factors to Consider When Investing in Pharmaceuticals Stocks
Before you invest in pharmaceuticals stocks, there are a few factors to consider. First, you want to make sure that the stocks you’re considering are reliable. This means that they have a proven track record of success and are unlikely to fail in the future. It is also important to consider each pharmaceuticals stock’s risk level. While you want to choose stocks with high potential for profit, you also want stocks that have low risk. If a company’s stock price drops significantly, it can be difficult to recover. You also want to make sure that you have a good understanding of the pharmaceuticals industry.
